DIVG - ETF AI Analysis

Top Page

Invesco S&P 500 High Dividend Growers ETF (DIVG)

Rating:70Outperform

Price Target:―

DIVG, the Invesco S&P 500 High Dividend Growers ETF, earns a solid overall rating driven mainly by strong holdings like Oneok and Merck, which combine robust financial performance, attractive valuations, and positive growth outlooks. Additional support comes from companies like Bristol-Myers Squibb and Pfizer, which are well-positioned for long-term growth despite some debt and product-related challenges, while weaker names such as LyondellBasell and Conagra, facing revenue and profitability pressures, modestly hold back the fund’s rating. The main risk factor is exposure to several companies with high leverage or operational headwinds, which could add volatility even though the portfolio is diversified across different businesses.

Positive Factors

Broad Sector Diversification

The fund spreads its investments across many sectors, which can help reduce the impact if any one industry struggles.

Several Strong Top Holdings

A number of the largest positions, such as LyondellBasell, Altria, and Franklin Resources, have shown strong year-to-date performance, supporting the ETF’s overall returns.

Consistent Recent Performance

The ETF has delivered steady gains over the past month, three months, and year-to-date, indicating relatively stable recent performance.

Negative Factors

Higher-Than-Average Expense Ratio

The fund’s expense ratio is on the higher side for a passive ETF, which means more of the returns are eaten up by fees over time.

Heavy U.S.-Only Exposure

With almost all assets invested in U.S. companies, the ETF offers little geographic diversification and is highly tied to the U.S. market.

Mixed Results Among Top Holdings

Some key positions like Prudential Financial and Conagra Brands have shown weak or negative year-to-date performance, which can drag on the fund’s overall results.

DIVG vs. SPDR S&P 500 ETF (SPY)

AUM10.29M

RegionNorth America

Expense Ratio0.39%

Beta0.58

IssuerInvesco

Inception DateDec 06, 2023

Dividend Yield2.99%

Asset ClassEquity

Index TrackedS&P 500 High Dividend Growth Index - Benchmark TR Gross

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume611

30 Day Avg. Volume1,378

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

37.67

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering100

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

DIVG Summary

DIVG is the Invesco S&P 500 High Dividend Growers ETF, which follows the S&P 500 High Dividend Growth Index. It focuses on large U.S. companies that have a history of steadily increasing their dividend payments. The fund holds well-known names like Pfizer and Bristol-Myers Squibb, along with firms in financials, utilities, and consumer defensive sectors. Someone might invest in DIVG to seek a mix of income from dividends and potential long-term growth, while staying diversified across many industries. A key risk is that stock prices and dividend payments can go up and down with the overall market.

How much will it cost me?The Invesco S&P 500 High Dividend Growers ETF (DIVG) has an expense ratio of 0.41%, which means you’ll pay $4.10 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific niche of high dividend growth companies, requiring more specialized management.

What would affect this ETF?The DIVG ETF, focused on U.S. large-cap companies with strong dividend growth, could benefit from stable economic conditions and increased investor demand for income-generating assets, especially in sectors like Financials and Consumer Defensive. However, rising interest rates or regulatory changes in key sectors such as Utilities and Real Estate may negatively impact performance, as these industries are sensitive to borrowing costs and policy shifts.

DIVG Top 10 Holdings

DIVG leans heavily into U.S. dividend stalwarts, with health care, financials, and defensive names doing much of the heavy lifting. Merck and Bristol-Myers are rising and helping anchor performance, while Pfizer is steady but not sprinting as it works through post-pandemic growing pains. On the income side, Altria and Oneok are pulling their weight, riding solid earnings and rich payouts. LyondellBasell and Conagra look more mixed, occasionally losing steam, which can tug on returns. Overall, the fund is U.S.-centric and tilted toward mature, cash-generating businesses rather than high-flying tech.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
LYB	LyondellBasell	3.77%	$387.49K	$18.79B	-25.52%	52 Neutral
CAG	Conagra Brands	2.23%	$229.01K	$9.14B	-26.98%	52 Neutral
BMY	Bristol-Myers Squibb	2.22%	$227.97K	$125.45B	4.25%	78 Outperform
PFE	Pfizer	2.06%	$211.44K	$154.31B	3.79%	74 Outperform
MO	Altria Group	1.96%	$201.50K	$116.25B	26.54%	64 Neutral
OKE	Oneok	1.87%	$192.70K	$52.16B	-14.86%	82 Outperform
BEN	Franklin Resources	1.87%	$192.48K	$14.12B	36.78%	74 Outperform
AES	AES	1.74%	$178.55K	$11.59B	49.91%	65 Neutral
MRK	Merck & Company	1.63%	$167.40K	$307.60B	35.20%	80 Outperform
KEY	KeyCorp	1.59%	$163.02K	$22.88B	27.34%	69 Neutral

DIVG Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

33.75

Positive

100DMA

32.87

Positive

200DMA

31.90

Positive

Market Momentum

MACD

0.54

Positive

RSI

64.07

Neutral

STOCH

44.22

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.93, equal to the 50-day MA of 33.75, and equal to the 200-day MA of 31.90, indicating a bullish trend. The MACD of 0.54 indicates Positive momentum. The RSI at 64.07 is Neutral, neither overbought nor oversold. The STOCH value of 44.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVG.

DIVG Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
DIVG	―	―	$10.29M	0.39%	70 Outperform
UPSD	―	―	$98.35M	0.79%	69 Neutral
LVDS	―	―	$94.03M	0.30%	72 Outperform
RWLC	―	―	$89.92M	0.32%	73 Outperform
ACEP	―	―	$89.13M	0.45%	71 Outperform
EGGY	―	―	$84.28M	0.89%	67 Neutral

Performance Comparison

DIVG

Invesco S&P 500 High Dividend Growers ETF

35.43

4.94

16.20%

UPSD

Aptus Large Cap Upside ETF

―

LVDS

JPMorgan Fundamental Data Science Large Value ETF

―

RWLC

Rayliant Quantitative Developed Market Equity ETF

―

ACEP

ARS Core Equity Portfolio ETF

―

EGGY

NestYield Dynamic Income Shield ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents